Materials Down After Inflation Data - Materials RoundupīNP Paribas Appoints Matt Passante as Head of Prime Sales for EMEA Kropz Secures ZAR250 Million Loan from Shareholder ARC Fund Shares Rise 14%ĮMEA Morning Briefing: ECB Decision in Focus SocGen open to sale of Equipment Finance unit in strategy review-sources Kropz says Elandsfontein gets ZAR250 million loan facility SocGen eyes return on tangible equity (ROTE) between 9% and 10% in 2026Īluminium deals delayed in Europe by cautious buyers amid weak demand Germany's Schott Pharma Targets Up to EUR4.3 Billion Valuation in Frankfurt IPOīNP Paribas Issues ZAR30 Million of Securities Due 2029 Investors temper pessimism on China, but bullish tilt remains distant prospectĮuropean Equities Close Sharply Lower in Monday Trading Bank, Homebuilder Stocks Lead DeclineīNP Paribas Appoints Scott Carter as Global Head of Investor CoverageĮuropean Midday Briefing: Cautious Start to Week Packed with Policy Decisions Sector Update: Financial Stocks Easing Late AfternoonĬitigroup Among Banks Exploring $15 Billion Funding for Indian Ocean ProjectīNP Paribas, HSBC, Others In Talks to Help Fund Indian Ocean ProjectĪldermore Said Plotting Takeover Bid for Co-operative BankįirstRand's Aldermore Plans Bid for the Co-operative Bank, Sky News Reports
Photo credits (cover page): onlyyouqj HBS A_B_C Adam (Adobe stock). The alternative performance measures are defined in the press release published jointly with 2Q23 presentation. The sum of values contained in the tables and analyses may differ slightly from the total reported due to rounding. Neither BNP Paribas nor its representatives shall have any liability whatsoever in negligence or otherwise for any loss however arising from any use of this presentation or its contents or otherwise arising in connection with this presentation or any other information or material discussed. The information contained in this presentation as it relates to parties other than BNP Paribas or derived from external sources has not been independently verified and no representation or warranty expressed or implied is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the information or opinions contained herein. It should be recalled in this regard that the Supervisory Review and Evaluation Process is carried out each year by the European Central Bank, which can modify each year its capital adequacy ratio requirements for BNP Paribas.
#On1 effects 10.5 update#
Any forward-looking statement contained in this presentation speaks as of the date of this presentation.īNP Paribas undertakes no obligation to publicly revise or update any forward-looking statements in light of new information or future events. Actual results may differ materially from those projected or implied in these forward-looking statements.
Those events are uncertain their outcome may differ from current expectations which may in turn significantly affect expected results. Forward-looking statements are not guarantees of future performance and are subject to inherent risks, uncertainties and assumptions about BNP Paribas and its subsidiaries and investments, developments of BNP Paribas and its subsidiaries, banking industry trends, future capital expenditures and acquisitions, changes in economic conditions globally, or in BNP Paribas' principal local markets, the competitive market and regulatory factors. Forward-looking statements include financial projections and estimates and their underlying assumptions, statements regarding plans, objectives and expectations with respect to future events, operations, products and services, and statements regarding future performance and synergies. This presentation includes forward-looking statements based on current beliefs and expectations about future events.
#On1 effects 10.5 series#
This presentation includes these quarterly series for 2022 as restated. The quarterly series for 2022 have been restated for these effects as if they had occurred on 1 January 2022. On, BNP Paribas reported restated quarterly series for 2022 to reflect for each quarter: (i) the application of IFRS 5 relating to disposal groups of assets and liabilities held for sale, following the sale of Bank of the West on 1 February 2023 (ii) the application of IFRS 17 (Insurance Contracts) and the application of IFRS 9 for insurance entities, effective 1 January 2023 (iii) the application of IAS 29 (Financial Reporting in Hyperinflationary Economies) to Türkiye, effective 1 January 2022 and (iv) the internal transfers of activities and results at Global Markets and Commercial & Personal Banking in Belgium. The figures included in this presentation are unaudited.
0 kommentar(er)
